M62 is an annual hybrid meeting, hosted by the Manchester Centre for Genomic Medicine which brings together clinicians across the M62 corridor to review dysmorphic and developmental disorder cases, enhance shared learning, and promote consistent, high-quality diagnostic approaches. Each year the meeting aims to strengthen regional collaboration, improve recognition of dysmorphic patterns, and support optimal patient diagnostic pathways. It is a relaxed forum allowing attendees to present known and unknown cases for discussion.
Previous M62 meetings have covered a broad range of clinical and translational genomics topics, including therapeutic strategies for genetic disorders, advanced genome sequencing applications, epigenomics and diagnostics through reanalysis of genomic data.
By attending M62 meetings, delegates engage with real-world case presentations and focused discussions highlighting how genomic insights inform diagnosis, management, and patient care.
If you have any queries or questions regarding the M62 annual meeting please contact the organising committee, Dr Laura Furness and Dr Kay Metcalfe.
Dr Laura Furness
ST6 Clinical Genomics
Dr Kay Metcalfe
Consultant Clinical Genetics
Previous M62 Meeting Materials